The spectrum of drugs to treat COVID-19 is also rapidly evolving, including antivirals (remdesivir, favipiravir), antimalarials (chloroquine, hydroxychloroquine), corticosteroids, anti-cytokine agents (IL-6 inhibitors), monoclonal antibodies and immunoglobulin therapy (convalescent plasma) [77]. This evidence concerns the gene IL6 and COVID-19.